chartexchange

Kyverna Therapeutics Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Kyverna Therapeutics, Inc. - KYTX

Business Wire | Nov 11, 2026 1:32 PM EST

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NasdaqGS: KYTX). According to a securities lawsuit filed against the Company, the registration statement and prospectus Kyverna used to conduct its initial public offering on February 8, 2024 (the “IPO”) misstated and/or omitt

Read original article